A look at the most common medications used in patients with acne. Casey Butrus, PharmD: Hilary, we have many different treatment options for acne, different mechanisms of action that have been around ...

Cutera Aims to Help Acne Sufferers Be Fully Present in Their Lives with the National Launch of AviClear™ BRISBANE, Calif.--(BUSINESS WIRE)-- Ninety percent of moderate to severe acne sufferers said ...

Please provide your email address to receive an email when new articles are posted on . IDP-126 — a combination of clindamycin, adapalene and benzoyl peroxide — reduced acne severity in about half of ...

Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...

Among nearly 20 different agents and treatment combinations, topical triple-agent fixed-dose combination (FDC) gel emerged as the most efficacious for moderate-to-severe acne. Researchers who ...

Please provide your email address to receive an email when new articles are posted on . Denifanstat, a fatty acid synthase inhibitor, was effective in the treatment of moderate to severe acne vulgaris ...

Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical trial in acne in China conducted by license partner Ascletis Ascletis ...

Over 50 million people across the US live with acne, a condition with no cure that often requires chronic treatment Sagimet Biosciences has announced positive results from the trial of its license ...

Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026 Company plans FDA discussion in Q3 2026 to advance Phase 3 program and potential label expansion More ...